Basilea Pharmaceutica (BPMUF) Short Interest Ratio & Short Volume $67.75 0.00 (0.00%) As of 08/7/2025 Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock Basilea Pharmaceutica Short Interest DataBasilea Pharmaceutica (BPMUF) has a short interest of 7,400 shares. This marks a 957.14% increase in short interest from the previous month. The short interest ratio (days to cover) is 74.0, indicating that it would take 74.0 days of the average trading volume of 1 shares to cover all short positions.Current Short Interest7,400 sharesPrevious Short Interest700 sharesChange Vs. Previous Month+957.14%Dollar Volume Sold Short$453.92 thousandShort Interest Ratio74.0 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares13,170,000 sharesPercentage of Shares Shorted0.06%Today's Trading Volume0 sharesAverage Trading Volume1 sharesToday's Volume Vs. Average0% Short Selling Basilea Pharmaceutica? Sign up to receive the latest short interest report for Basilea Pharmaceutica and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBPMUF Short Interest Over TimeBPMUF Days to Cover Over TimeBPMUF Percentage of Float Shorted Over Time Basilea Pharmaceutica Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20257,400 shares $453.92 thousand +957.1%N/A74 $61.34 6/30/2025700 shares $40.39 thousand +600.0%0.0%0 $57.70 6/15/2025100 shares $5.77 thousand No Change0.0%1 $57.70 5/31/2025100 shares $4.75 thousand -97.6%0.0%0 $47.50 5/15/20254,100 shares $194.75 thousand +4,000.0%0.0%0 $47.50 4/30/2025100 shares $4.75 thousand -97.2%N/A0 $47.50 4/15/20253,600 shares $183.60 thousand +3,500.0%0.0%36 $51.00 3/31/2025100 shares $5.40 thousand -95.2%0.0%1 $54.00 3/15/20252,100 shares $110.94 thousand -86.6%0.0%21 $52.83 2/28/202515,700 shares $829.43 thousand -29.0%0.1%0 $52.83 Get the Latest News and Ratings for BPMUF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Basilea Pharmaceutica and its competitors with MarketBeat's FREE daily newsletter. 2/15/202522,100 shares $1.17 million No Change0.2%0 $52.83 1/31/202522,100 shares $1.17 million +34.8%N/A0 $52.83 1/15/202516,400 shares $866.41 thousand No ChangeN/A0 $52.83 12/31/202416,400 shares $866.41 thousand -34.4%N/A0 $52.83 12/15/202425,000 shares $1.32 million -11.0%N/A0 $52.83 11/30/202428,100 shares $1.48 million +5.2%N/A0 $52.83 11/15/202426,700 shares $1.41 million -11.3%N/A0 $52.83 10/31/202430,100 shares $1.59 million -1.0%N/A0 $52.83 10/15/202430,400 shares $1.61 million -0.3%N/A304 $52.83 9/30/202430,500 shares $1.56 million -2.2%N/A305 $51.26 9/15/202431,200 shares $1.60 million No ChangeN/A0 $51.26 8/31/202431,200 shares $1.60 million +0.3%N/A0 $51.26 8/15/202431,100 shares $1.46 million -57.0%N/A0 $47.00 7/31/202472,300 shares $3.40 million -14.4%N/A723 $47.00 7/15/202484,500 shares $4.07 million -8.9%N/A0 $48.15 6/30/202492,800 shares $4.47 million +3.3%N/A0 $48.15 6/15/202489,800 shares $4.32 million +19.9%N/A0 $48.15 5/31/202474,900 shares $3.61 million -9.1%N/A749 $48.15 5/15/202482,400 shares $3.66 million -3.4%N/A0 $44.45 4/30/202485,300 shares $3.79 million -59.3%N/A0 $44.45 4/15/2024209,600 shares $9.32 million -6.5%N/A2096 $44.45 3/31/2024224,100 shares $9.13 million +0.6%N/A0 $40.75 3/15/2024222,800 shares $9.08 million +3.3%N/A0 $40.75 2/29/2024215,600 shares $8.79 million -14.3%N/A0 $40.75 2/15/2024251,600 shares $10.25 million -9.1%N/A2516 $40.75 1/15/2024268,800 shares $11.02 million +3.0%N/A0 $41.00 12/31/2023260,900 shares $10.70 million +1.5%N/A0 $41.00 12/15/2023257,100 shares $10.54 million +2.0%N/A0 $41.00 11/30/2023252,100 shares $10.34 million -1.9%N/A0 $41.00 11/15/2023256,900 shares $10.53 million -0.7%N/A0 $41.00He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad)The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.See his full breakdown of the seven stocks to own now 10/31/2023258,800 shares $10.61 million -9.0%N/A2588 $41.00 10/15/2023284,400 shares $14.22 million -1.4%N/A0 $50.00 9/30/2023288,300 shares $14.42 million +7.5%N/A0 $50.00 9/15/2023268,300 shares $13.42 million -2.9%N/A0 $50.00 8/31/2023276,400 shares $13.82 million -9.2%N/A0 $50.00 8/15/2023304,300 shares $15.22 million +2.6%N/A0 $50.00 7/31/2023296,600 shares $14.83 million -12.1%N/A0 $50.00 7/15/2023337,300 shares $16.87 million -2.9%N/A0 $50.00 6/30/2023347,200 shares $17.36 million +4.0%N/A0 $50.00 6/15/2023333,900 shares $16.70 million -1.6%N/A3339 $50.00 5/31/2023339,200 shares $16.96 million +0.6%N/A3392 $50.00 5/15/2023337,300 shares $17.54 million -14.7%N/A3373 $52.00 4/30/2023395,600 shares $20.57 million +0.4%N/A0 $52.00 4/15/2023394,000 shares $20.49 million +0.5%N/A0 $52.00 3/31/2023392,200 shares $20.39 million +5.5%N/A0 $52.00 3/15/2023371,700 shares $19.33 million +0.5%N/A0 $52.00 2/28/2023369,700 shares $19.22 million -4.5%N/A0 $52.00 2/15/2023386,900 shares $20.12 million +3.6%N/A0 $52.00 1/31/2023373,400 shares $19.42 million +1.3%N/A0 $52.00 1/15/2023368,800 shares $19.18 million -0.1%N/A0 $52.00 12/30/2022369,000 shares $19.19 million +0.2%N/A0 $52.00 12/15/2022368,300 shares $19.15 million -0.9%N/A0 $52.00 11/30/2022371,800 shares $19.33 million -2.2%N/A3718 $52.00 11/15/2022380,200 shares $17.49 million -0.1%N/A3802 $46.00 10/31/2022380,600 shares $15.60 million -3.7%N/A0 $41.00 10/15/2022395,100 shares $16.20 million -2.7%N/A0 $41.00 9/30/2022406,100 shares $16.65 million +0.5%N/A0 $41.00 9/15/2022404,200 shares $16.57 million +6.2%N/A4042 $41.00 8/31/2022380,700 shares $15.61 million -5.5%N/A0 $41.00 8/15/2022402,900 shares $16.52 million -21.8%N/A0 $41.00 7/31/2022515,400 shares $21.13 million -19.0%N/A0 $41.00 7/15/2022635,900 shares $26.07 million -1.9%N/A0 $41.00 6/30/2022648,000 shares $26.57 million -1.3%N/A0 $41.00 6/15/2022656,300 shares $26.91 million -2.0%N/A0 $41.00 5/31/2022669,900 shares $27.47 million -0.6%N/A0 $41.00 5/15/2022673,600 shares $27.62 million -0.3%N/A0 $41.00 4/30/2022675,600 shares $27.70 million +2.3%N/A0 $41.00 4/15/2022660,500 shares $27.08 million +4.2%N/A0 $41.00 3/31/2022634,000 shares $25.99 million -2.3%N/A0 $41.00 3/15/2022649,000 shares $26.61 million -1.2%N/A0 $41.00 2/28/2022656,900 shares $26.93 million +4.5%N/A0 $41.00 2/15/2022628,900 shares $25.78 million +0.5%N/A6289 $41.00 1/31/2022625,900 shares $25.66 million -1.2%N/A0 $41.00 1/15/2022633,200 shares $25.96 million -1.1%N/A0 $41.00 12/31/2021640,000 shares $26.24 million -2.8%N/A0 $41.00 12/15/2021658,300 shares $26.99 million +0.6%N/A6583 $41.00 11/30/2021654,300 shares $30.75 million +1.8%N/A0 $47.00 11/15/2021642,500 shares $30.20 million +17.1%N/A0 $47.00 10/29/2021548,700 shares $25.79 million +8.0%N/A0 $47.00 10/15/2021508,100 shares $23.88 million +0.8%N/A5081 $47.00He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad)The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.See his full breakdown of the seven stocks to own now 9/30/2021504,000 shares $23.18 million +5.1%N/A0 $46.00 9/15/2021479,400 shares $22.05 million -3.3%N/A0 $46.00 8/31/2021495,700 shares $22.80 million -4.1%N/A0 $46.00 8/13/2021516,600 shares $23.76 million -2.7%N/A0 $46.00 7/30/2021530,800 shares $24.42 million -6.3%N/A5308 $46.00 7/15/2021566,400 shares $28.21 million -1.7%N/A0 $49.80 6/30/2021576,400 shares $28.71 million -1.1%N/A5764 $49.80 6/15/2021582,600 shares $26.82 million -2.5%N/A0 $46.04 5/28/2021597,800 shares $27.52 million +0.7%N/A0 $46.04 5/14/2021593,500 shares $26.74 million -1.1%N/A5935 $45.05 4/30/2021600,100 shares $31.14 million -0.6%N/A6001 $51.89 4/15/2021603,400 shares $30.29 million -2.6%N/A6034 $50.20 3/31/2021619,400 shares $30.85 million -0.9%N/A6194 $49.80 3/15/2021625,200 shares $31.99 million +10.1%N/A6252 $51.16 2/26/2021567,800 shares $32.93 million +1.7%N/A5678 $58.00 2/12/2021558,100 shares $33.21 million +0.9%N/A0 $59.50 1/29/2021553,100 shares $32.91 million +0.9%N/A0 $59.50 1/15/2021550,300 shares $32.17 million -1.9%N/A5503 $58.46 12/31/2020548,800 shares $33.11 million -0.3%N/A5488 $60.34 12/15/2020550,300 shares $32.63 million -1.9%N/A5503 $59.30 11/30/2020560,800 shares $33.31 million -2.9%N/A5608 $59.40 11/15/2020577,400 shares $31.18 million +2.0%N/A0 $54.00 10/30/2020566,000 shares $30.56 million +13.8%N/A5660 $54.00 10/15/2020497,200 shares $27.15 million -4.9%N/A4972 $54.60 9/30/2020522,600 shares $29.01 million -1.3%N/A0 $55.52 9/15/2020529,300 shares $29.39 million -1.0%N/A5293 $55.52 8/31/2020534,500 shares $29.68 million -2.5%N/A2672.5 $55.52 8/14/2020548,300 shares $30.41 million +5.9%N/A0 $55.47 BPMUF Short Interest - Frequently Asked Questions What is Basilea Pharmaceutica's current short interest? Short interest is the volume of Basilea Pharmaceutica shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 7,400 shares of BPMUF short. Learn More on Basilea Pharmaceutica's current short interest. What is a good short interest ratio for Basilea Pharmaceutica? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BPMUF shares currently have a short interest ratio of 74.0. Learn More on Basilea Pharmaceutica's short interest ratio. Is Basilea Pharmaceutica's short interest increasing or decreasing? Basilea Pharmaceutica saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 7,400 shares, an increase of 957.1% from the previous total of 700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Basilea Pharmaceutica's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Basilea Pharmaceutica: SpringWorks Therapeutics (9.19%), Scholar Rock Holding Corporation (14.92%), MoonLake Immunotherapeutics (11.98%), Protagonist Therapeutics, Inc. (9.93%), HUTCHMED (China) Limited Sponsored ADR (0.20%), Apellis Pharmaceuticals, Inc. (13.06%), Kymera Therapeutics, Inc. (11.62%), Ultragenyx Pharmaceutical Inc. (9.13%), Immunovant, Inc. (29.97%), Alvotech (1.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Basilea Pharmaceutica stock? Short selling BPMUF is an investing strategy that aims to generate trading profit from Basilea Pharmaceutica as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Basilea Pharmaceutica? A short squeeze for Basilea Pharmaceutica occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BPMUF, which in turn drives the price of the stock up even further. How often is Basilea Pharmaceutica's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BPMUF, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies SWTX Short Interest SRRK Short Interest MLTX Short Interest PTGX Short Interest HCM Short Interest APLS Short Interest KYMR Short Interest RARE Short Interest IMVT Short Interest ALVO Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:BPMUF) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Basilea Pharmaceutica AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Basilea Pharmaceutica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BPMUF Stock Alerts